Literature DB >> 33447900

A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of Migraine.

Kaveh Ebahimzadeh1, Mahdi Gholipour2, Mohammad Samadian1, Mohammad Taheri3, Soudeh Ghafouri-Fard4.   

Abstract

Migraine is a common neurovascular condition. This disorder has a complex genetic background. Several single-nucleotide polymorphisms (SNPs) or mutations within genes regulating glutamatergic neurotransmission, cortical excitability, ion channels, and solute carriers have been associated with polygenic and monogenic forms of migraine. SNPs within ACE, DBH, TRPM8, COMT, GABRQ, CALCA, TRPV1, and other genes have been reported to affect the risk of migraine or the associated clinical parameters. The distribution of some HLA alleles within the HLA-DRB1, HLA-DR2, HLA-B, and HLA-C regions have also been found to differ between migraineurs and healthy subjects. In addition, certain mitochondrial DNA changes and polymorphisms in this region have been shown to increase the risk of migraine. A few functional studies have investigated the molecular mechanisms contributing to these genetic factors in the development of migraine. Here we review studies evaluating the role of genetic polymorphisms and mRNA/miRNA dysregulation in migraine.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Expression; Migraine; Polymorphism; miRNA

Mesh:

Substances:

Year:  2021        PMID: 33447900     DOI: 10.1007/s12031-020-01788-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  56 in total

1.  The influence of genetic constitution on migraine drug responses.

Authors:  Anne Francke Christensen; Ann-Louise Esserlind; Thomas Werge; Hreinn Stefánsson; Kári Stefánsson; Jes Olesen
Journal:  Cephalalgia       Date:  2015-10-26       Impact factor: 6.292

2.  Angiotensin-converting enzyme gene rs4343 polymorphism increases susceptibility to migraine.

Authors:  Atieh Abedin-Do; Sara Pouriamanesh; Zeeba Kamaliyan; Reza Mirfakhraie
Journal:  CNS Neurosci Ther       Date:  2017-06-18       Impact factor: 5.243

3.  Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods.

Authors:  Hjalte H Andersen; Meg Duroux; Parisa Gazerani
Journal:  Mol Neurobiol       Date:  2015-02-01       Impact factor: 5.590

4.  Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine.

Authors:  Piero Barbanti; Fiorella Guadagni; Maria Laura De Marchis; Cristiano Ialongo; Gabriella Egeo; Luisa Fofi; Cinzia Aurilia; Domenica Lovero; David Della-Morte; Patrizia Ferroni; Raffaele Palmirotta
Journal:  Neurol Sci       Date:  2019-04-10       Impact factor: 3.307

5.  Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study.

Authors:  Chun-Yu Cheng; Shih-Pin Chen; Yi-Chu Liao; Jong-Ling Fuh; Yen-Feng Wang; Shuu-Jiun Wang
Journal:  Cephalalgia       Date:  2017-11-10       Impact factor: 6.292

6.  Genome-wide association study identifies novel susceptibility loci for migraine in Han Chinese resided in Taiwan.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Ming-Yi Chung; Ying-Chao Lin; Yi-Chu Liao; Yen-Feng Wang; Chia-Lin Hsu; Ueng-Cheng Yang; Ming-Wei Lin; Jen-Jie Chiou; Po-Jen Wang; Ping-Kun Chen; Pi-Chuan Fan; Jer-Yuan Wu; Yuan-Tsong Chen; Lung-Sen Kao; Cathy Shen-Jang Fann; Shuu-Jiun Wang
Journal:  Cephalalgia       Date:  2017-02-17       Impact factor: 6.292

7.  The effect of melatonin on gene expression of calcitonin gene-related peptide and some proinflammatory mediators in patients with pure menstrual migraine.

Authors:  Mohammad Ansari; Azam Karkhaneh; Asma Kheirollahi; Solaleh Emamgholipour; Mohammad Hessam Rafiee
Journal:  Acta Neurol Belg       Date:  2017-06-05       Impact factor: 2.396

8.  Prevalence of HLA DQB1*0602 allele in patients with migraine.

Authors:  Fernando Morgadinho Santos Coelho; Márcia Pradella-Hallinan; Paulo Corrêa Abud; Mario Predazzoli Neto; Fabio Moreira; Lia Rita Azeredo Bittencourt; Mario Fernandes Pietro Peres; Sérgio Tufik
Journal:  Arq Neuropsiquiatr       Date:  2007-12       Impact factor: 1.420

9.  Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.

Authors:  Gulfer Atasayar; Isil Ezgi Eryilmaz; Necdet Karli; Unal Egeli; Mehmet Zarifoglu; Gulsah Cecener; Ozlem Taskapilioglu; Berrin Tunca; Oznur Yildirim; Secil Ak; Gulcin Tezcan; Fatma Ezgi Can
Journal:  J Neurol Sci       Date:  2016-05-13       Impact factor: 3.181

10.  Mitochondrial genome-wide association study of migraine - the HUNT Study.

Authors:  Sigrid Børte; John-Anker Zwart; Anne Heidi Skogholt; Maiken Elvestad Gabrielsen; Laurent F Thomas; Lars G Fritsche; Ida Surakka; Jonas B Nielsen; Wei Zhou; Brooke N Wolford; Magnus D Vigeland; Knut Hagen; Espen Saxhaug Kristoffersen; Dale R Nyholt; Daniel I Chasman; Ben M Brumpton; Cristen J Willer; Bendik S Winsvold
Journal:  Cephalalgia       Date:  2020-02-14       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.